Investor Presentation for Q2FY2025-26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mitsu Chem Plast reported Q2 FY26 revenue of ₹92.42 crore, up 13.6% YoY from ₹81.46 crore, with EBITDA rising to ₹5.88 crore (margin at 6.37% vs 5.82% YoY) and net profit at ₹1.88 crore versus ₹1.14 crore in Q2 FY25. The company has outlined an ambitious roadmap to triple its revenue to ₹1,000 crore by FY28, built on four pillars: healthcare furniture brand 'Furnastra', packaging products, operational excellence, and data-driven marketing. Export revenues surged 144% in FY25, with the company now serving 17 countries and participating in global trade fairs like Arab Health and Medica. Long-term borrowings have steadily come down from ₹31.96 crore in FY21 to ₹11.43 crore in FY25, indicating improving balance sheet strength.
Positive — Q2 FY26 showed broad-based YoY growth in revenue, profitability, and margins, validating the company's growth trajectory. The explicit ₹1,000 crore FY28 target with a clear strategic framework could attract investor interest, though execution on margin expansion remains key given long-term margin compression trends.